References
Gessain A, Saal F, Gout O, Daniel MT, Flandrin G, Thé G de, Périès J, Sigaux F (1990) High human T-cell lymphotropic virus type 1 proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese and African patients with tropical spastic paraparesis. Blood 75:428–433
Gout O, Baulac M, Gessain A, Semah F, Saal F, Périès J, Cabrol C, Foucault-Fretz C, Laplane D, Thé G de (1990) Rapid development of myelopathy after HTLV-1 infection acquired by transfusion during cardiac transplantation. N Engl J Med 322:383–388
Matsushita S, Mitsuya H, Reitz MS, Broder S (1987) Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type 1. J Clin Invest 80:393–400
Roman G, Vernant JC, Osame M (eds) (1989) HTLV-1 and the nervous system. (Neurology and neurobiology, vol 51), Liss, New York
Tendler CJ, Greenberg SJ, Blattner WA, Manns A, Murphy E, Fleisher T, Hanchard B, Morgan O, Burton JD, Nelson DL, Waldmann TA (1990) Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type 1-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 87:5218–5222
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gout, O., Gessain, A., Iba-Zizen, M. et al. The effect of zidovudine on chronic myelopathy associated with HTLV-1. J Neurol 238, 108–109 (1991). https://doi.org/10.1007/BF00315691
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315691